Calorie-enriched diet and lack of exercise are causing a worldwide surge of obesity, insulin
resistance and lipid accretion in liver (ie hepatic steatosis), which can lead to steatohepatitis …

METHODS—A Medline search without limitations of date (as of October 2005), language, or
humans was carried out by the authors. The following medical subject headings were …

NONALCOHOLIC FATTY LIVER DISEASE is emerging as the most common chronic liver
condition in the Western world. It is associated with insulin resistance and frequently occurs …

In uncontrolled clinical studies, ursodeoxycholic acid (UDCA) had a beneficial effect on
nonalcoholic steatohepatitis (NASH). However, a large controlled trial using UDCA (13‐15 …

Patients with nonalcoholic fatty liver disease (NAFLD) often have dyslipidemia along with
other features of metabolic syndrome such as obesity, diabetes mellitus, and hypertension …

The spectrum of nonalcoholic fatty liver disease (NAFLD) ranges from asymptomatic
steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. Hepatic steatosis occurs …

BACKGROUND/AIMS: Non-alcoholic fatty liver disease (NAFLD) pathogenesis remains
unknown. Due to the emerging role of free cholesterol (FC) in NAFLD, our aim was to …

Non-alcoholic fatty liver disease (NAFLD) is common and may progress to cirrhosis and its
complications. The pathogenesis of steatosis and cellular injury is thought to be related …

OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) is defined as the spectrum of benign
fatty liver to necroinflammation and fibrosis. Its prevalence has been found to be as high as …

Non‐alcoholic fatty liver disease (NAFLD), the most common chronic liver disease in the
Western world, is tightly associated with obesity and metabolic syndrome. NAFLD entails an …